Why did Biogen pay up for Apellis Pharmaceuticals?

Because this may be less about buying a drug and more about buying a nephrology platform.

Our latest argues that kidney disease is starting to look like biotech’s next strategic battleground, and that Biogen’s Apellis deal may be an early signal of where the industry is heading.

Read more: https://biotech.industryexaminer.com/biogen-apellis-kidney-disease-nephrology-biotech/

#Biotech #KidneyDisease #Nephrology #Biogen #TechNews

Biogen’s $5.6 Billion Apellis Deal Is Really a Bet on Kidney Disease - Biotech Industry Examiner

The acquisition gives Biogen near-term revenue, but the more important prize may be something pharma rarely gets to buy fully formed: a nephrology commercial

Biotech Industry Examiner
When to see a doctor for kidney disease? #kidneydisease #kidneyhealth #nephrology #kidney ... Continue to: https://www.facebook.com/reel/1665710901121830/

Beautifully written, and deeply resonating.
The long middle of a chronically terminal illness is a rough one to endure, traverse, witness, accept, and talk about.

https://www.theguardian.com/society/2026/mar/22/i-have-stage-four-cancer-there-will-be-no-cure-but-death-isnt-necessarily-imminent-this-is-how-it-feels-to-live-in-the-long-middle

#SystemicSclerosis #ILD and #KidneyDisease is my long middle, on top of #BreastCancer survivor-ness, with scanxiety every few months - blood & kidney tests, CT scans, digestion tract monitoring. I'm not yet at dialysis, but know it's not too far away.

I have stage four cancer – there will be no cure, but death isn’t necessarily imminent: this is how it feels to live in the long middle

When you are cured, the world cheers; when you are dying, it mourns. But when you are simply maintaining, the world is at a loss

The Guardian
Can chronic glomerulonephritis cause kidney failure? #kidney #kidneydisease #glomerulonephritis
... Continue to: https://youtube.com/shorts/VLQWbgF1S-8?si=I5gMSMdShawSf8hK